SCOTTO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 904
EU - Europa 521
AS - Asia 244
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.694
Nazione #
US - Stati Uniti d'America 878
IT - Italia 230
SG - Singapore 166
DE - Germania 117
NL - Olanda 98
CN - Cina 43
CA - Canada 25
IN - India 19
CH - Svizzera 18
CI - Costa d'Avorio 18
IE - Irlanda 13
FI - Finlandia 11
GB - Regno Unito 11
FR - Francia 7
VN - Vietnam 7
UA - Ucraina 6
EG - Egitto 4
BE - Belgio 2
HK - Hong Kong 2
JP - Giappone 2
PK - Pakistan 2
RS - Serbia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
MX - Messico 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 1.694
Città #
Chandler 152
Ashburn 143
Singapore 127
Amsterdam 92
Naples 81
Santa Clara 40
Krefeld 31
Millbury 30
Lawrence 25
Des Moines 24
Napoli 24
Boston 22
Ottawa 21
Boardman 20
Basel 17
Rome 14
Nanjing 12
Wilmington 11
Pozzuoli 10
Princeton 10
Seattle 10
Washington 10
Beijing 6
Kronberg 6
Bologna 4
Caserta 4
Dong Ket 4
Formia 4
Hebei 4
Los Angeles 4
Marseille 4
Milan 4
Nanchang 4
Pune 4
Brescia 3
Dung 3
Fairfield 3
Lappeenranta 3
Norwalk 3
Cairo 2
Castellammare Di Stabia 2
Council Bluffs 2
Dallas 2
Florence 2
Hong Kong 2
Hyderabad 2
Jiaxing 2
Naaldwijk 2
Nuremberg 2
Prato 2
Redwood City 2
Richmond 2
Shenyang 2
Tianjin 2
Tokyo 2
Abidjan 1
Alcamo 1
Augusta 1
Aversa 1
Bayreuth 1
Brussels 1
Burlington 1
Castellammare di Stabia 1
Cava De' Tirreni 1
Changsha 1
Chengdu 1
Chittagong 1
Crispano 1
Downers Grove 1
Dubai 1
Dublin 1
Duncan 1
Edinburgh 1
Ercolano 1
Foggia 1
Forest City 1
Frankfurt am Main 1
Galveston 1
Gent 1
Hanover 1
Helsinki 1
Islamabad 1
La Canada Flintridge 1
London 1
Mariglianella 1
Melbourne 1
Messina 1
Monmouth Junction 1
Monteforte Irpino 1
Monterrey 1
Montreal 1
Mountain View 1
Mumbai 1
Palermo 1
Pisticci 1
Poggiomarino 1
Richland 1
San Francisco 1
San Giorgio Del Sannio 1
San Salvatore Telesino 1
Totale 1.070
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 132
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 65
Asunaprevir for hepatitis C: A safety evaluation 52
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 50
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 49
Does compulsory vaccination limit personal freedom? Ethical issues 48
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 44
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 41
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 41
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 40
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 40
Factors Affecting Outcome of Tuberculosis in Children in Italy: An Ecological Study 39
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 39
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 39
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 38
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 37
Chest CT in COVID-19 patients: structured vs conventional reporting 36
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 35
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 35
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 34
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 33
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 32
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 31
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 30
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 30
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 29
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 29
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 27
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 27
The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study 27
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 26
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 26
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 26
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 25
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 25
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial 24
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 24
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 23
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 22
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 22
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 22
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 22
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 21
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 21
Recommendations for treating children with drug-resistant tuberculosis 20
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 20
Diabetes and COVID-19: The potential role of mTOR 19
Indications to hospital admission and isolation of children with possible or defined tuberculosis: Systematic review and proposed recommendations for pediatric patients leaving in developed countries 19
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 18
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 17
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 17
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 17
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 17
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 16
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 12
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy 10
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 8
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 8
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 6
Update on the Management of Surgical Site Infections 6
Monoclonal antibodies against Clostridium difficile infection in the pipeline 6
Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy 5
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 5
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 4
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 4
Totale 1.812
Categoria #
all - tutte 10.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 11 3 4 5 1 9 7 4
2020/202191 17 2 3 2 27 2 4 4 12 6 7 5
2021/2022197 3 2 1 0 0 13 2 10 14 21 53 78
2022/2023602 35 22 20 24 53 72 15 161 68 101 27 4
2023/2024487 18 68 76 41 42 85 3 43 13 6 49 43
2024/2025225 72 42 11 47 53 0 0 0 0 0 0 0
Totale 1.812